Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tomsk National Research Medical Center of the Russian Academy of Sciences
University of California, Davis
Replimune Inc.
Carevive Systems, Inc.
University of Pennsylvania
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Eli Lilly and Company
Novartis
Stanford University
Varian, a Siemens Healthineers Company
Complement Theory Inc.
City of Hope Medical Center
UNICANCER
City of Hope Medical Center
AstraZeneca
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Milton S. Hershey Medical Center
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute
Baltimore VA Medical Center
Comprehensive Support Project for Oncology Research